Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Zentalis Pharmaceuticals Inc (NQ: ZNTL ) 3.060 +0.170 (+5.88%) Streaming Delayed Price Updated: 9:55 AM EDT, Aug 15, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Zentalis Pharmaceuticals Inc < Previous 1 2 3 Next > Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2021 September 29, 2021 Upgrades For Spirit AeroSystems Holdings Inc (NYSE: Via Benzinga Stocks That Hit 52-Week Highs On Thursday August 26, 2021 Before 10 a.m. ET on Thursday, 91 companies hit new 52-week highs. Interesting Points: The largest company by market cap to set a new 52-week high was Alphabet (... Via Benzinga The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO August 26, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 25) Abbvie Inc. (NYSE: ABBV)... Via Benzinga Exposures COVID-19 The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study September 16, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Alcon Inc. (NYSE: ALC)... Via Benzinga Week In Review: China Life Science Posts $1.3 Billion In Deals August 07, 2021 Pacific Biosciences, a San Francisco Bay area company offering long-read sequencing platforms, will acquire Omniome for up to $800 million. Zai Lab and Schrödinger formed a collaboration to develop a... Via Talk Markets The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs September 15, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)... Via Benzinga Exposures COVID-19 Week In Review: BeiGene Plans $3 Billion IPO On Shanghai STAR Market July 03, 2021 BeiGene of Beijing has been approved to stage a $3 billion IPO on the Shanghai Star Stock Exchange. It will be the first Chinese biopharma to be listed in Shanghai, Hong Kong, and the US. Via Talk Markets Topics Initial Public Offering Exposures Securities Market The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout September 14, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE... Via Benzinga Exposures COVID-19 Zentalis Secures $150M In Equity Funding June 29, 2021 Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL) priced an underwritten public offering of 3.1 million shares at $48.50 per share, for gross proceeds of approximately $... Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session June 28, 2021 Gainers SCWorx (NASDAQ:WORX) shares rose ... Via Benzinga The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test September 10, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (... Via Benzinga 10 Biggest Price Target Changes For Wednesday May 19, 2021 Barclays reduced Apple Inc. (NASDAQ: AAPL) price target from $138 to $134. Apple shares fell 1.1% to $123.47 in pre-market trading. UBS lifted Wells Fargo & Company (NYSE:... Via Benzinga Stocks That Hit 52-Week Highs On Tuesday April 27, 2021 Tuesday's morning session saw 205 companies set new 52-week highs. Interesting Highlights: Wells Fargo (NYSE:WFC) was the largest firm on a market cap basis to set a... Via Benzinga The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization September 09, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:... Via Benzinga Exposures COVID-19 10 Biggest Price Target Changes For Tuesday April 13, 2021 Rosenblatt boosted NVIDIA Corporation (NASDAQ: NVDA) price target from $700 to $800. NVIDIA shares fell 0.2% to $607.00 in pre-market trading. Keybanc boosted the price target... Via Benzinga The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod September 08, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc... Via Benzinga Exposures Product Safety Zentalis's Early WEE1 Inhibitor Data Shows 'Exceptional' Response In Solid Tumor Study, Plans Combination Trials April 12, 2021 Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL) has announced initial efficacy and safety data from the Phase 1 dose-escalation portion of its ongoing Phase 1/2... Via Benzinga 38 Stocks Moving In Friday's Mid-Day Session April 09, 2021 Gainers Celcuity Inc. (NASDAQ: CELC) shares jumped 64.5% to $23.54 after the company announced a worldwide licensing agreement with Pfizer to develop and commercialize... Via Benzinga The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab September 02, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV... Via Benzinga Exposures COVID-19 Product Safety The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering September 01, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31) AC Immune SA (NASDAQ: ACIU... Via Benzinga The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical August 31, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)... Via Benzinga Stocks That Hit 52-Week Highs On Friday August 27, 2021 Before 10 a.m. ET Friday, 183 stocks hit new 52-week highs. Areas of Significance: Alphabet (NASDAQ:GOOG) was the biggest firm by market cap to hit a new 52-week... Via Benzinga The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration August 27, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)... Via Benzinga Topics Intellectual Property Exposures Intellectual Property The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout June 29, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 28) Alexion Pharmaceuticals,... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For May 21, 2021 May 21, 2021 Upgrades According to JP Morgan, the prior rating for ResMed Inc (NYSE:RMD) was changed from Neutral to Overweight. For the third quarter, ResMed had an EPS of $1.30,... Via Benzinga The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping April 28, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout April 27, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ... Via Benzinga Topics Intellectual Property Exposures Intellectual Property 51 Biggest Movers From Friday April 12, 2021 Gainers Celcuity Inc. (NASDAQ: CELC) shares climbed 50.9% to close at $21.60 on Friday after the company announced a worldwide licensing agreement with Pfizer to develop and... Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.